Pharmaceuticals

Femasys founder talks about Femaseed’s technology designed to support fertility treatment

bexib
By bexib 0 Min Read

In an interview with Pharm Exec Associate Editor Don Tracy, Femasys founder and CEO Kathy Lee-Sepsick explains how Femaseed works to support women struggling with infertility.

You Might Also Like

Big Pharma leaders balance affordability and access as IRAs and supply constraints grow

Despite admissions committee rejection, Lycos CEO sees potential for MDMA drug

FDA Approves Arcutis Biotherapeutics’ Xolive for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis

Pharma Pulse 6/26/24: Empowering women in pharmacies, AI helps fraudsters, and more

FDA Expands Approval of Sarepta Therapeutics’ Erevidys for Treatment of Duchenne Muscular Dystrophy

Share This Article
Previous Article Link July 5, 2024 | Naked Capitalism
Next Article Hamster Combat Surpasses 239 Million Users in 81 Days – Investorempires.com
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Wells Fargo is committed to risk infrastructure and efficiency initiatives
Banking
Creative Engineering Under Pressure by Jesse Velez and Ben Eadie
Manufacturing
Chart: Global Retail CEOs’ Q4 2024 Outlook
Retail & E-commerce
ABBANK in Vietnam announces SME digital banking platform powered by Backbase
Fintech